Recurrent Acute Biphenotypic Leukemia Active Not Recruiting Phase 1 Trials for Cytarabine (DB00987)
Also known as: Acute, recurrent Biphenotypic Leukemia
| Indication | Status | Phase |
|---|---|---|
| DBCOND0106027 (Recurrent Acute Biphenotypic Leukemia) | Active Not Recruiting | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT04526795 | Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory Leukemia | Treatment |